|
1
|
Tonon G, Wong KK, Maulik G, Brennan C,
Feng B, Zhang Y, Khatry DB, Protopopov A, You MJ, Aguirre AJ, et
al: High-resolution genomic profiles of human lung cancer. Proc
Natl Acad Sci USA. 102:9625–9630. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li H, Li QD, Wang MS, Li FJ, Li QH, Ma XJ
and Wang da N: Smoking and air pollution exposure and lung cancer
mortality in Zhaoyuan County. Int J Hyg Environ Health. 216:63–70.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen M, Liu X, Du J, Wang XJ and Xia L:
Differentiated regulation of immune-response related genes between
LUAD and LUSC subtypes of lung cancers. Oncotarget. 8:133–144.
2017.PubMed/NCBI
|
|
4
|
Corner J: Is late diagnosis in lung cancer
inevitable? Rt Nursing. 2004.
|
|
5
|
Mirror: Deadly delay; most lung cancer
victims diagnosed too late to save them. Mirror. 2009.
|
|
6
|
Merino-Zamorano C, Delgado P, de Retana
Fernández S, Fernández-Cadenas I, Rodríguez-Luna D, Montaner J and
Hernández-Guillamon M: Identification of plasma biomarkers of human
intracerebral hemorrhage subtypes through microarray technology. J
Stroke Cerebrovasc Dis. 25:665–671. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang YH, Shen L, Shen Y, Chen XD and
Jiang LS: Study on key genes and regulatory networks associated
with osteoporosis by microarray technology. Genetic Test Mol
Biomarkers. 17:625–630. 2013. View Article : Google Scholar
|
|
8
|
Golub TR, Slonim DK, Tamayo P, Huard C,
Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri
MA, et al: Molecular classification of cancer: Class discovery and
class prediction by gene expression monitoring. Science.
286:531–537. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
DeRisi J, Penland L, Brown PO, Bittner ML,
Meltzer PS, Ray M, Chen Y, Su YA and Trent JM: Use of a cDNA
microarray to analyse gene expression patterns in human cancer. Nat
Genet. 14:457–460. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Garber ME, Troyanskaya OG, Schluens K,
Petersen S, Thaesler Z, Pacyna-Gengelbach M, van de Rijn M, Rosen
GD, Perou CM, Whyte RI, et al: Diversity of gene expression in
adenocarcinoma of the lung. Proc Natl Acad Sci USA. 98:13784–13789.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Soda M, Choi YL, Enomoto M, Takada S,
Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K,
Hatanaka H, et al: Identification of the transforming EML4-ALK
fusion gene in non-small-cell lung cancer. Nature. 448:561–566.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gordon GJ, Jensen RV, Hsiao LL, Gullans
SR, Blumenstock JE, Ramaswamy S, Richards WG, Sugarbaker DJ and
Bueno R: Translation of microarray data into clinically relevant
cancer diagnostic tests using gene expression ratios in lung cancer
and mesothelioma. Cancer Res. 62:4963–4967. 2002.PubMed/NCBI
|
|
13
|
Wheelan SJ, Murillo Martínez F and Boeke
JD: The incredible shrinking world of DNA microarrays. Mol Biosyst.
4:726–732. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Z, Li Q, Geng L, Chen X and Bi K: Use
of the local false discovery rate for identification of metabolic
biomarkers in rat urine following genkwa Flos-induced
hepatotoxicity. PLoS One. 8:e674512013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cline MS, Craft B, Swatloski T, Goldman M,
Ma S, Haussler D and Zhu J: Exploring TCGA pan-cancer data at the
UCSC cancer genomics browser. Scientific Rep. 3:26522013.
View Article : Google Scholar
|
|
16
|
Nam DH, Jin JY and Joo KM: Method for
preparing patient-specific glioblastoma animal model, and use
thereof. US Patent 9750826B2. Filed June 6, 2013; issued April 16.
2015.
|
|
17
|
Lu TP, Tsai MH, Lee JM, Hsu CP, Chen PC,
Lin CW, Shih JY, Yang PC, Hsiao CK, Lai LC and Chuang EY:
Identification of a novel biomarker, SEMA5A, for non-small cell
lung carcinoma in nonsmoking women. Cancer Epidemiol Biomarkers
Prev. 19:2590–2597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Landi MT, Dracheva T, Rotunno M, Figueroa
JD, Liu H, Dasgupta A, Mann FE, Fukuoka J, Hames M, Bergen AW, et
al: Gene expression signature of cigarette smoking and its role in
lung adenocarcinoma development and survival. PLoS One.
3:e16512008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Su LJ, Chang CW, Wu YC, Chen KC, Lin CJ,
Liang SC, Lin CH, Whang-Peng J, Hsu SL, Chen CH and Huang CY:
Selection of DDX5 as a novel internal control for Q-RT-PCR from
microarray data using a block bootstrap re-sampling scheme. BMC
Genomics. 8:1402007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Heber S and Sick B: Quality assessment of
Affymetrix GeneChip data. OMICS. 10:358–368. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu C, Irizarry R and Gentry J: gcrma:
Background adjustment using sequence information. 2005.
|
|
22
|
Huang HC, Zheng S and Zhao Z: Application
of Pearson correlation coefficient (PCC) and Kolmogorov-Smirnov
distance (KSD) metrics to identify disease-specific biomarker
genes. BMC Bioinformatics. 11 Suppl 4:S232010. View Article : Google Scholar
|
|
23
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wickham H: Ggplot2: Elegant Graphics for
Data Analysis. Springer; New York, NY: 2016, View Article : Google Scholar
|
|
25
|
Huang DW, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pallant J: SPSS Survival Manual.
McGraw-Hill Education; Buckingham, UK: 2013, View Article : Google Scholar
|
|
27
|
Norusis MJ: SPSS: SPSS for Windows, base
system user's guide release 6.0. SPSS, Inc; 1993
|
|
28
|
Batura-Gabryel H and Foremska-Iciek J:
Lung cancer in the elderly-increasing epidemiological problem of
21st century. Rocz Akad Med Bialymst. 50 Suppl 1:S152–S155.
2005.
|
|
29
|
Goeckenjan G: Lung cancer-historical
development, current status, future prospects. Pneumologie.
64:555–559. 2010.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Medenica M, Medenica M, Bojović O,
Soldatović I and Durutović I: Changing trends in incidence of lung
cancer by histological type in Montenegro. Srp Arh Celok Lek.
142:23–28. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rothschild SI: Advanced and metastatic
lung cancer-what is new in the diagnosis and therapy? Praxis (Bern
1994). 104:745–750. 2015.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Moyer VA; U.S. Preventive Services Task
Force: Screening for lung cancer: U.S. Preventive Services Task
Force recommendation statement, . Ann Intern Med. 160:330–338.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Raaschou-Nielsen O, Andersen ZJ, Beelen R,
Samoli E, Stafoggia M, Weinmayr G, Hoffmann B, Fischer P,
Nieuwenhuijsen MJ, Brunekreef B, et al: Air pollution and lung
cancer incidence in 17 European cohorts: Prospective analyses from
the european study of cohorts for air pollution effects (ESCAPE).
Lancet Oncol. 14:813–822. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fajersztajn L, Veras M, Barrozo LV and
Saldiva P: Air pollution: A potentially modifiable risk factor for
lung cancer. Nat Rev Cancer. 13:674–678. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Levi F, Bosetti C, Fernandez E, Hill C,
Lucchini F, Negri E and La Vecchia C: Trends in lung cancer among
young European women: The rising epidemic in France and Spain. Int
J Cancer. 121:462–465. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kang HG, Lee SY, Jeon HS, Choi YY, Kim S,
Lee WK, Lee HC, Choi JE, Bae EY, Yoo SS, et al: A functional
polymorphism in CSF1R gene is a novel susceptibility marker for
lung cancer among never-smoking females. J Thorac Oncol.
9:1647–1655. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen M, Wang X and Xia L: Comparison of
alternative splicing in lung adenocarcinoma and lung squamous
carcinoma. Shenzhen Daxue Xuebao. 34:332017.
|
|
38
|
Dzhorbenadze RA, Gagua RK and Gerzmava
OKh: Lung cancer morbidity rate among the Georgian population
according to sex and age and expected morbidity prognosis. Georgian
Med News. 65–68. 2005.(In Russian). PubMed/NCBI
|
|
39
|
Suciu B, Bud V, Copotoiu C, Brânzaniuc K,
Copotoiu R, Fodor D and Butiurca V: Factors affecting early
morbidity and mortality in non-small cell lung cancer surgery, the
experience of Surgical Clinic No. 1, Tg. Mureş. Rev Med Chir Soc
Med Nat Iasi. 115:116–126. 2011.PubMed/NCBI
|
|
40
|
Imielinski M, Berger AH, Hammerman PS,
Hernandez B, Pugh TJ, Hodis E, Cho J, Suh J, Capelletti M,
Sivachenko A, et al: Mapping the hallmarks of lung adenocarcinoma
with massively parallel sequencing. Cell. 150:1107–1120. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hubbard NE, Chen QJ, Sickafoose LK, Wood
MB, Gregg JP, Abrahamsson NM, Engelberg JA, Walls JE and Borowsky
AD: Transgenic mammary epithelial osteopontin (spp1) expression
induces proliferation and alveologenesis. Genes Cancer. 4:201–212.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang XM, Li J, Yan MX, Liu L, Jia DS, Geng
Q, Lin HC, He XH, Li JJ and Yao M: Integrative analyses identify
osteopontin, LAMB3 and ITGB1 as critical pro-metastatic genes for
lung cancer. PLoS One. 8:e557142013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Psallidas I, Stathopoulos GT, Maniatis NA,
Magkouta S, Moschos C, Karabela SP, Kollintza A, Simoes DC, Kardara
M, Vassiliou S, et al: Secreted phosphoprotein-1 directly provokes
vascular leakage to foster malignant pleural effusion. Oncogene.
32:528–535. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wesselkamper SC, Case LM, Henning LN,
Borchers MT, Tichelaar JW, Mason JM, Dragin N, Medvedovic M, Sartor
MA, Tomlinson CR and Leikauf GD: Gene expression changes during the
development of acute lung injury: Role of transforming growth
factor beta. Am J Respir Crit Care Med. 172:1399–1411. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
AGER: Advanced glycosylation end
product-specific receptor. Feb 11–2018.
|
|
46
|
Xu Y, Toure F, Qu W, Lin L, Song F, Shen
X, Rosario R, Garcia J, Schmidt AM and Yan SF: Advanced glycation
end product (AGE)-receptor for AGE (RAGE) signaling and
up-regulation of Egr-1 in hypoxic macrophages. J Biol Chem.
285:23233–23240. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chong SF, Lee JH, Zelikin AN and Caruso F:
Tuning the permeability of polymer hydrogel capsules: An
investigation of cross-linking density, membrane thickness, and
cross-linkers. Langmuir. 27:1724–1730. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Stav D, Bar I and Sandbank J: Usefulness
of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung
adenocarcinoma. Int J Biol Markers. 22:108–113. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jing RR, Cui M, Sun BL, Yu J and Wang HM:
Tissue-specific expression profiling of receptor for advanced
glycation end products and its soluble forms in esophageal and lung
cancer. Genet Test Mol Biomarkers. 14:355–361. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Beucher J, Boëlle PY, Busson PF,
Muselet-Charlier C, Clement A and Corvol H: French C F Modifier
Gene Study Investigators: AGER-429T/C is associated with an
increased lung disease severity in cystic fibrosis. PLoS One.
7:e419132012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Entrez gene: FCN3 ficolin
(collagen/fibrinogen domain containing) 3 [Homo sapiens (human)].
Jun 20–2018.
|
|
52
|
Szala A, Sawicki S, Swierzko AS, Szemraj
J, Sniadecki M, Michalski M, Kaluzynski A, Lukasiewicz J,
Maciejewska A, Wydra D, et al: Ficolin-2 and ficolin-3 in women
with malignant and benign ovarian tumours. Cancer Immunol
Immunother. 62:1411–1419. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Shi I, Sadraei Hashemi N, Duan ZH and Shi
T: Aberrant signaling pathways in squamous cell lung carcinoma.
Cancer Inform. 10:273–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ou D, Yang H, Hua D, Xiao S and Yang L:
Novel roles of TMEM100: Inhibition metastasis and proliferation of
hepatocellular carcinoma. Oncotarget. 6:17379–17390. 2015.
View Article : Google Scholar : PubMed/NCBI
|
